HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Line Between Beauty And Pharma Blurs As Both Chase Aesthetics Market

This article was originally published in The Rose Sheet

Executive Summary

As beauty firms seek credibility for their products through science-based claims and drug companies move into the consumer aesthetics market, the boundary between prescription and over-the-counter is growing fuzzier

You may also be interested in...



Reliant Links With Philips To Develop Laser Skin-Care Device For Home Use

Reliant Technologies Inc., developer of Fraxel laser systems, has partnered with electronics giant Philips to develop laser skin-rejuvenation technology for use at home, taking a cue from some of the industry's biggest players that are making moves toward the aesthetic devices market

Clinique, Allergan To Create Skin Care For Botox, Dermal Filler Recipients

Clinique and pharmaceutical firm Allergan have teamed up in an effort to capitalize on the growing demand for skin-care products that complement aesthetic procedures performed in physicians' offices, according to a Jan. 24 release

Clinique, Allergan To Create Skin Care For Botox, Dermal Filler Recipients

Clinique and pharmaceutical firm Allergan have teamed up in an effort to capitalize on the growing demand for skin-care products that complement aesthetic procedures performed in physicians' offices, according to a Jan. 24 release

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel